Anticancer Medicine / VEGFR Inhibitor

Axitinib Tablets

Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Axitinib Tablets (Inlybest). High-quality, reliable, affordable medicine.

Formulation Tablets
Standard WHO-GMP Certified Quality
Supply Type Global Export & Institutional Supply
Email Directly
WHO-GMP Certified
Global Export Ready
Quality Assured

Formulation Insights

Comprehensive Medical Overview

Axitinib Tablets

Classification: Anticancer Medicine / VEGFR Inhibitor

About Axitinib Tablets

Axitinib is a selective oral tyrosine kinase inhibitor designed to inhibit vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3), primarily indicated in advanced renal cell carcinoma.

Axitinib Tablets (Inlybest) Manufactured by Aprazer Healthcare

Inlybest is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.